Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 1618 1759 3791
This examiner grants 60% of resolved cases
Jonghwan NMN Baek works in Art Unit 1618 of Tech Center 3700. The examiner has 5 resolved cases and an allowance rate of 60.0 percent. The median days to allowance is 998, which is the timeframe for the limited outcomes recorded. With only 5 resolved cases, these metrics are based on a very small sample of the examiner's work.
The interview lift is 0.0 percent, suggesting that interviews have not yet shown a measurable impact on the 60.0 percent baseline allowance rate. Practitioners should focus on strong written submissions to navigate the 998-day median pendency in Art Unit 1618. The 60.0 percent allowance rate provides a starting point for understanding the examiner's docket, but more resolutions are needed to establish a stable profile. Applicants should monitor how these figures evolve as more cases are resolved in Tech Center 3700. The 998-day timeline is the primary guide for expectations at this stage.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18066441 | FORMATION AND USE OF EMBEDDED SOLUTIONS IN NANOSCALE MATERIALS | Final Rejection | The Regents of the University of California |
| 18196229 | IMAGING PHANTOM | Final Rejection | The Regents of the University of Michigan |
| 18434796 | PRECISION RADIOPHARMACEUTICAL THERAPY OF LYMPHOMA AND OTHER DISEASES | Non-Final OA | WASHINGTON UNIVERSITY |
| 17860684 | METHOD FOR CREATING A RENAL INJURY MODEL TO SCREEN MOLECULES FOR THE TREATMENT OF RENAL INJURY | Non-Final OA | Bayer Aktiengesellschaft |
| 18253857 | SYNTHESIS OF [18F]-LABELED THYMIDINE ANALOGUES | Final Rejection | UNIVERSITY OF SOUTHERN CALIFORNIA |
| 18280427 | Loading of Alginate Microspheres | Final Rejection | Board of Regents, The University of Texas System |
| 18260598 | FOLATE RECEPTOR-TARGETED CONJUGATES, COMPOSITIONS, AND DELIVERY TO THE CENTRAL NERVOUS SYSTEM | Non-Final OA | PURDUE RESEARCH FOUNDATION |
| 18336708 | FIBROBLAST ACTIVATION PROTEIN-TARGETED MAGNETIC RESONANCE IMAGING AGENTS, COMPOSITIONS, AND METHODS OF USE | Non-Final OA | Purdue Research Foundation |
| 18700598 | FLUORINE-CONTAINING COMPOUND AND CONTRAST AGENT | Non-Final OA | TDK CORPORATION |
| 18273362 | EMBOLIC MATERIAL AND METHOD FOR PRODUCING THE SAME | Non-Final OA | KEIO UNIVERSITY |
| 18550354 | VOLATILE BIOMARKERS FOR COLORECTAL CANCER | Non-Final OA | IMPERIAL COLLEGE INNOVATIONS LIMITED |
| 18567543 | HIGH PERFORMANCE AQUEOUS HALIDE PEROVSKITE NANOCRYSTALS | Non-Final OA | Nanyang Technological University |
| 18571271 | VINYLATED KETO ESTERS WITH APPLICABILITY IN SIGNAL ENHANCED MAGNETIC RESONANCE IMAGING AND SYNTHESIS THEREOF | Non-Final OA | MAX-PLANCK-GESELLSCHAFT ZUR FÖRDERUNG DER WISSENSCHAFTEN E. V. |
| 17054618 | MICROSPHERES CONTAINING RADIOACTIVE ISOTOPES AND OTHER MARKERS AND ASSOCIATED METHODS | Non-Final OA | Bard Peripheral Vascular, Inc. |
| 18570949 | METHODS FOR IN VIVO DELIVERY OF MICROBES TO HUMAN MICROENVIRONMENTS | Non-Final OA | Baylor College of Medicine |
| 18555802 | FRAGRANCE FOR IMPROVING INVIGORATION STATE AND METHOD OF ASSESSING | Non-Final OA | GIVAUDAN SA |
| 18289333 | COMPLEX FOR BIOIMAGING, AND DIAGNOSIS OR TREATMENT OF CANCER | Final Rejection | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy